beta subunit of bacterial RNA polymerase — Drug Target

All drugs that target beta subunit of bacterial RNA polymerase — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

Bacterial RNA polymerase inhibitor · Bactericidal antibiotic

Phase 3 pipeline (1)

• Standard dose rifampicin · Radboud University Medical Center · Bacterial RNA polymerase inhibitor · Infectious Diseases
  Rifampicin inhibits bacterial RNA synthesis by binding to the beta subunit of bacterial RNA polymerase.

Phase 1 pipeline (1)

• AB-106, Rifampicin · Nuvation Bio Inc. · Bactericidal antibiotic · Infectious Disease
  Inhibits bacterial RNA synthesis by binding to the beta subunit of bacterial RNA polymerase